Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia

Odity Mukherjee, Jun Wang, Michael Gitcho, Sumi Chakraverty, Lisa Taylor-Reinwald, Shantia Shears, John S K Kauwe, Joanne Norton, Denise Levitch, Eileen H. Bigio, Kimmo J. Hatanpaa, Charles L. White, John C. Morris, Nigel J. Cairns, Alison Goate

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Frontotemporal dementia (FTD) is a clinical term encompassing dementia characterized by the presence of two major phenotypes: 1) behavioral and personality disorder, and 2) language disorder, which includes primary progressive aphasia and semantic dementia. Recently, the gene for familial frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U) linked to chromosome 17 was cloned. In the present study, 62 unrelated patients from the Washington University Alzheimer's Disease Research Center and the Midwest Consortium for FTD with clinically diagnosed FTD and/or neuropathologically characterized cases of FTLD-U with or without motor neuron disease (MND) were screened for mutations in the progranulin gene (GRN; also PGRN). We discovered two pathogenic mutations in four families: 1) a single-base substitution within the 3′ splice acceptor site of intron 6/exon 7 (g.5913A > G [IVS6-2A > G]) causing skipping of exon 7 and premature termination of the coding sequence (PTC); and 2) a missense mutation in exon 1 (g.4068C > A) introducing a charged amino acid in the hydrophobic core of the signal peptide at residue 9 (p.A9D). Functional analysis in mutation carriers for the splice acceptor site mutation revealed a 50% decrease in GRN mRNA and protein levels, supporting haploinsufficiency. In contrast, there was no significant difference in the total GRN mRNA between cases and controls carrying the p.A9D mutation. Further, subcellular fractionation and confocal microscopy indicate that although the mutant protein is expressed, it is not secreted, and appears to be trapped within an intracellular compartment, possibly resulting in a functional haploinsufficiency.

Original languageEnglish (US)
Pages (from-to)512-521
Number of pages10
JournalHuman Mutation
Volume29
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Frontotemporal Dementia
Frontotemporal Lobar Degeneration
RNA Splice Sites
Mutation
Haploinsufficiency
Exons
Primary Progressive Aphasia
Language Disorders
Motor Neuron Disease
Messenger RNA
Chromosomes, Human, Pair 17
Personality Disorders
Missense Mutation
Mutant Proteins
Protein Sorting Signals
Ubiquitin
Confocal Microscopy
Introns
Genes
Dementia

Keywords

  • Frontotemporal dementia
  • FTD
  • Granulin
  • GRN
  • PGRN
  • Progranulin

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Mukherjee, O., Wang, J., Gitcho, M., Chakraverty, S., Taylor-Reinwald, L., Shears, S., ... Goate, A. (2008). Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Human Mutation, 29(4), 512-521. https://doi.org/10.1002/humu.20681

Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. / Mukherjee, Odity; Wang, Jun; Gitcho, Michael; Chakraverty, Sumi; Taylor-Reinwald, Lisa; Shears, Shantia; Kauwe, John S K; Norton, Joanne; Levitch, Denise; Bigio, Eileen H.; Hatanpaa, Kimmo J.; White, Charles L.; Morris, John C.; Cairns, Nigel J.; Goate, Alison.

In: Human Mutation, Vol. 29, No. 4, 04.2008, p. 512-521.

Research output: Contribution to journalArticle

Mukherjee, O, Wang, J, Gitcho, M, Chakraverty, S, Taylor-Reinwald, L, Shears, S, Kauwe, JSK, Norton, J, Levitch, D, Bigio, EH, Hatanpaa, KJ, White, CL, Morris, JC, Cairns, NJ & Goate, A 2008, 'Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia', Human Mutation, vol. 29, no. 4, pp. 512-521. https://doi.org/10.1002/humu.20681
Mukherjee O, Wang J, Gitcho M, Chakraverty S, Taylor-Reinwald L, Shears S et al. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Human Mutation. 2008 Apr;29(4):512-521. https://doi.org/10.1002/humu.20681
Mukherjee, Odity ; Wang, Jun ; Gitcho, Michael ; Chakraverty, Sumi ; Taylor-Reinwald, Lisa ; Shears, Shantia ; Kauwe, John S K ; Norton, Joanne ; Levitch, Denise ; Bigio, Eileen H. ; Hatanpaa, Kimmo J. ; White, Charles L. ; Morris, John C. ; Cairns, Nigel J. ; Goate, Alison. / Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. In: Human Mutation. 2008 ; Vol. 29, No. 4. pp. 512-521.
@article{7b14044935f547b3af8bfa106fac4584,
title = "Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia",
abstract = "Frontotemporal dementia (FTD) is a clinical term encompassing dementia characterized by the presence of two major phenotypes: 1) behavioral and personality disorder, and 2) language disorder, which includes primary progressive aphasia and semantic dementia. Recently, the gene for familial frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U) linked to chromosome 17 was cloned. In the present study, 62 unrelated patients from the Washington University Alzheimer's Disease Research Center and the Midwest Consortium for FTD with clinically diagnosed FTD and/or neuropathologically characterized cases of FTLD-U with or without motor neuron disease (MND) were screened for mutations in the progranulin gene (GRN; also PGRN). We discovered two pathogenic mutations in four families: 1) a single-base substitution within the 3′ splice acceptor site of intron 6/exon 7 (g.5913A > G [IVS6-2A > G]) causing skipping of exon 7 and premature termination of the coding sequence (PTC); and 2) a missense mutation in exon 1 (g.4068C > A) introducing a charged amino acid in the hydrophobic core of the signal peptide at residue 9 (p.A9D). Functional analysis in mutation carriers for the splice acceptor site mutation revealed a 50{\%} decrease in GRN mRNA and protein levels, supporting haploinsufficiency. In contrast, there was no significant difference in the total GRN mRNA between cases and controls carrying the p.A9D mutation. Further, subcellular fractionation and confocal microscopy indicate that although the mutant protein is expressed, it is not secreted, and appears to be trapped within an intracellular compartment, possibly resulting in a functional haploinsufficiency.",
keywords = "Frontotemporal dementia, FTD, Granulin, GRN, PGRN, Progranulin",
author = "Odity Mukherjee and Jun Wang and Michael Gitcho and Sumi Chakraverty and Lisa Taylor-Reinwald and Shantia Shears and Kauwe, {John S K} and Joanne Norton and Denise Levitch and Bigio, {Eileen H.} and Hatanpaa, {Kimmo J.} and White, {Charles L.} and Morris, {John C.} and Cairns, {Nigel J.} and Alison Goate",
year = "2008",
month = "4",
doi = "10.1002/humu.20681",
language = "English (US)",
volume = "29",
pages = "512--521",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia

AU - Mukherjee, Odity

AU - Wang, Jun

AU - Gitcho, Michael

AU - Chakraverty, Sumi

AU - Taylor-Reinwald, Lisa

AU - Shears, Shantia

AU - Kauwe, John S K

AU - Norton, Joanne

AU - Levitch, Denise

AU - Bigio, Eileen H.

AU - Hatanpaa, Kimmo J.

AU - White, Charles L.

AU - Morris, John C.

AU - Cairns, Nigel J.

AU - Goate, Alison

PY - 2008/4

Y1 - 2008/4

N2 - Frontotemporal dementia (FTD) is a clinical term encompassing dementia characterized by the presence of two major phenotypes: 1) behavioral and personality disorder, and 2) language disorder, which includes primary progressive aphasia and semantic dementia. Recently, the gene for familial frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U) linked to chromosome 17 was cloned. In the present study, 62 unrelated patients from the Washington University Alzheimer's Disease Research Center and the Midwest Consortium for FTD with clinically diagnosed FTD and/or neuropathologically characterized cases of FTLD-U with or without motor neuron disease (MND) were screened for mutations in the progranulin gene (GRN; also PGRN). We discovered two pathogenic mutations in four families: 1) a single-base substitution within the 3′ splice acceptor site of intron 6/exon 7 (g.5913A > G [IVS6-2A > G]) causing skipping of exon 7 and premature termination of the coding sequence (PTC); and 2) a missense mutation in exon 1 (g.4068C > A) introducing a charged amino acid in the hydrophobic core of the signal peptide at residue 9 (p.A9D). Functional analysis in mutation carriers for the splice acceptor site mutation revealed a 50% decrease in GRN mRNA and protein levels, supporting haploinsufficiency. In contrast, there was no significant difference in the total GRN mRNA between cases and controls carrying the p.A9D mutation. Further, subcellular fractionation and confocal microscopy indicate that although the mutant protein is expressed, it is not secreted, and appears to be trapped within an intracellular compartment, possibly resulting in a functional haploinsufficiency.

AB - Frontotemporal dementia (FTD) is a clinical term encompassing dementia characterized by the presence of two major phenotypes: 1) behavioral and personality disorder, and 2) language disorder, which includes primary progressive aphasia and semantic dementia. Recently, the gene for familial frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U) linked to chromosome 17 was cloned. In the present study, 62 unrelated patients from the Washington University Alzheimer's Disease Research Center and the Midwest Consortium for FTD with clinically diagnosed FTD and/or neuropathologically characterized cases of FTLD-U with or without motor neuron disease (MND) were screened for mutations in the progranulin gene (GRN; also PGRN). We discovered two pathogenic mutations in four families: 1) a single-base substitution within the 3′ splice acceptor site of intron 6/exon 7 (g.5913A > G [IVS6-2A > G]) causing skipping of exon 7 and premature termination of the coding sequence (PTC); and 2) a missense mutation in exon 1 (g.4068C > A) introducing a charged amino acid in the hydrophobic core of the signal peptide at residue 9 (p.A9D). Functional analysis in mutation carriers for the splice acceptor site mutation revealed a 50% decrease in GRN mRNA and protein levels, supporting haploinsufficiency. In contrast, there was no significant difference in the total GRN mRNA between cases and controls carrying the p.A9D mutation. Further, subcellular fractionation and confocal microscopy indicate that although the mutant protein is expressed, it is not secreted, and appears to be trapped within an intracellular compartment, possibly resulting in a functional haploinsufficiency.

KW - Frontotemporal dementia

KW - FTD

KW - Granulin

KW - GRN

KW - PGRN

KW - Progranulin

UR - http://www.scopus.com/inward/record.url?scp=42049108445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049108445&partnerID=8YFLogxK

U2 - 10.1002/humu.20681

DO - 10.1002/humu.20681

M3 - Article

VL - 29

SP - 512

EP - 521

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -